Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-08

FDA Approved: DEFERASIROX — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved an original ANDA for deferasirox (generic) manufactured by Aurobindo Pharma Limited, expanding access to iron chelation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)